Medicina
Departamento
Pharmacoeconomics and Outcomes Research Iberia
Pozuelo de Alarcón, EspañaPublicaciones en colaboración con investigadoras/es de Pharmacoeconomics and Outcomes Research Iberia (4)
2023
-
Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
Rheumatology and Therapy, Vol. 10, Núm. 5, pp. 1319-1333
2021
-
Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with cd-33 positive acute myeloid leukaemia in spain
ClinicoEconomics and Outcomes Research, Vol. 13, pp. 263-277
2020
-
Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus
BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1
2019
-
Second-line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients
Clinical Rheumatology, Vol. 38, Núm. 12, pp. 3521-3528